| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00022 | 1 |